Company Filing History:
Years Active: 2019-2025
Title: Innovations of Jason Duex in Cancer Research
Introduction
Jason Duex is an accomplished inventor based in Denver, CO (US). He has made significant contributions to the field of cancer research through his innovative work. With a total of 3 patents, Duex is recognized for his advancements in phospholipid compositions that have potential applications in cancer treatment.
Latest Patents
One of Jason Duex's latest patents involves phospholipid compositions that utilize a modified egg yolk extract as an effective anti-cancer agent. This innovative composition includes specific fractions of phosphatidylcholines and sphingomyelins that are modified and produced through a chemical synthesis applied to the extract. The resulting product demonstrates a beneficial effect on the inhibition of cancerous cell growth. Additionally, methods of administering these compositions are also described in his patent.
Career Highlights
Duex is currently associated with Machavert Pharmaceuticals LLC, where he continues to develop groundbreaking solutions in the pharmaceutical industry. His work is pivotal in advancing therapeutic options for cancer patients.
Collaborations
Jason Duex collaborates with talented individuals such as Lukas Kobr and Gregory F Miknis, contributing to a dynamic research environment that fosters innovation.
Conclusion
In summary, Jason Duex's contributions to cancer research through his patented innovations highlight his commitment to improving treatment options. His work at Machavert Pharmaceuticals LLC and collaborations with fellow researchers further enhance the impact of his inventions in the medical field.